Literature DB >> 23690585

Identifying dynamic tuberculosis case-finding policies for HIV/TB coepidemics.

Reza Yaesoubi1, Ted Cohen.   

Abstract

The global tuberculosis (TB) control plan has historically emphasized passive case finding (PCF) as the most practical approach for identifying TB suspects in high burden settings. The success of this approach in controlling TB depends on infectious individuals recognizing their symptoms and voluntarily seeking diagnosis rapidly enough to reduce onward transmission. It now appears, at least in some settings, that more intensified case-finding (ICF) approaches may be needed to control TB transmission; these more aggressive approaches for detecting as-yet undiagnosed cases obviously require additional resources to implement. Given that TB control programs are resource constrained and that the incremental yield of ICF is expected to wane over time as the pool of undiagnosed cases is depleted, a tool that can help policymakers to identify when to implement or suspend an ICF intervention would be valuable. In this article, we propose dynamic case-finding policies that allow policymakers to use existing observations about the epidemic and resource availability to determine when to switch between PCF and ICF to efficiently use resources to optimize population health. Using mathematical models of TB/HIV coepidemics, we show that dynamic policies strictly dominate static policies that prespecify a frequency and duration of rounds of ICF. We also find that the use of a diagnostic tool with better sensitivity for detecting smear-negative cases (e.g., Xpert MTB/RIF) further improves the incremental benefit of these dynamic case-finding policies.

Entities:  

Keywords:  approximate dynamic programming; cost-effectiveness; dynamic resource allocation; mathematical model; screening

Mesh:

Year:  2013        PMID: 23690585      PMCID: PMC3677479          DOI: 10.1073/pnas.1218770110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Comparison of symptoms and treatment outcomes between actively and passively detected tuberculosis cases: the additional value of active case finding.

Authors:  S den Boon; S Verver; C J Lombard; E D Bateman; E M Irusen; D A Enarson; M W Borgdorff; N Beyers
Journal:  Epidemiol Infect       Date:  2008-01-04       Impact factor: 2.451

2.  Modeling the impact of global tuberculosis control strategies.

Authors:  C J Murray; J A Salomon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

3.  Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.

Authors:  Grant Theron; Jonny Peter; Richard van Zyl-Smit; Hridesh Mishra; Elizabeth Streicher; Samuel Murray; Rodney Dawson; Andrew Whitelaw; Michael Hoelscher; Surendra Sharma; Madhukar Pai; Robin Warren; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

4.  Expanding tuberculosis case detection by screening household contacts.

Authors:  Mercedes C Becerra; Iliana F Pachao-Torreblanca; Jaime Bayona; Rosa Celi; Sonya S Shin; Jim Yong Kim; Paul E Farmer; Megan Murray
Journal:  Public Health Rep       Date:  2005 May-Jun       Impact factor: 2.792

Review 5.  Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection.

Authors:  K M De Cock; R E Chaisson
Journal:  Int J Tuberc Lung Dis       Date:  1999-06       Impact factor: 2.373

Review 6.  Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes.

Authors:  Haileyesus Getahun; Mark Harrington; Rick O'Brien; Paul Nunn
Journal:  Lancet       Date:  2007-06-16       Impact factor: 79.321

7.  A socio-epidemiological study of out-patients attending a city tuberculosis clinic in India to judge the place of specialized centres in a tuberculosis control programme.

Authors:  D R Nagpaul; M K Vishwanath; G Dwarakanath
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

8.  LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement.

Authors:  U Mack; G B Migliori; M Sester; H L Rieder; S Ehlers; D Goletti; A Bossink; K Magdorf; C Hölscher; B Kampmann; S M Arend; A Detjen; G Bothamley; J P Zellweger; H Milburn; R Diel; P Ravn; F Cobelens; P J Cardona; B Kan; I Solovic; R Duarte; D M Cirillo
Journal:  Eur Respir J       Date:  2009-05       Impact factor: 16.671

9.  The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia.

Authors:  A M Elliott; B Halwiindi; R J Hayes; N Luo; G Tembo; L Machiels; C Bem; G Steenbergen; J O Pobee; P P Nunn
Journal:  J Trop Med Hyg       Date:  1993-02

Review 10.  Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis.

Authors:  Katharina Kranzer; Rein Mgj Houben; Judith R Glynn; Linda-Gail Bekker; Robin Wood; Stephen D Lawn
Journal:  Lancet Infect Dis       Date:  2010-02       Impact factor: 25.071

View more
  15 in total

1.  Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis.

Authors:  Florian M Marx; Ted Cohen; Nicolas A Menzies; Joshua A Salomon; Grant Theron; Reza Yaesoubi
Journal:  Lancet Glob Health       Date:  2020-09       Impact factor: 26.763

2.  Effectiveness of contact investigations for tuberculosis control in Arkansas.

Authors:  Giorgio Guzzetta; Marco Ajelli; Zhenhua Yang; Leonard N Mukasa; Naveen Patil; Joseph H Bates; Denise E Kirschner; Stefano Merler
Journal:  J Theor Biol       Date:  2015-06-05       Impact factor: 2.691

3.  Adaptive Policies to Balance Health Benefits and Economic Costs of Physical Distancing Interventions during the COVID-19 Pandemic.

Authors:  Reza Yaesoubi; Joshua Havumaki; Melanie H Chitwood; Nicolas A Menzies; Gregg Gonsalves; Joshua A Salomon; A David Paltiel; Ted Cohen
Journal:  Med Decis Making       Date:  2021-01-27       Impact factor: 2.583

4.  Optimizing the protection of research participants and personnel in HIV-related research where TB is prevalent: practical solutions for improving infection control.

Authors:  Jason E Farley; Timothy F Landers; Catherine Godfrey; Virginia Lipke; Jeremy Sugarman
Journal:  J Acquir Immune Defic Syndr       Date:  2014-01-01       Impact factor: 3.731

Review 5.  Permutations of time and place in tuberculosis.

Authors:  Paul T Elkington; Jon S Friedland
Journal:  Lancet Infect Dis       Date:  2015-08-28       Impact factor: 25.071

6.  Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South Africa.

Authors:  Jennifer A Gilbert; Elisa F Long; Ralph P Brooks; Gerald H Friedland; Anthony P Moll; Jeffrey P Townsend; Alison P Galvani; Sheela V Shenoi
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

7.  How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India.

Authors:  Andrew S Azman; Jonathan E Golub; David W Dowdy
Journal:  BMC Med       Date:  2014-10-30       Impact factor: 8.775

8.  Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa.

Authors:  Jennifer A Gilbert; Sheela V Shenoi; Anthony P Moll; Gerald H Friedland; A David Paltiel; Alison P Galvani
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

9.  Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study.

Authors:  Florian M Marx; Reza Yaesoubi; Nicolas A Menzies; Joshua A Salomon; Alyssa Bilinski; Nulda Beyers; Ted Cohen
Journal:  Lancet Glob Health       Date:  2018-02-19       Impact factor: 26.763

10.  Modeling tuberculosis dynamics with the presence of hyper-susceptible individuals for Ho Chi Minh City from 1996 to 2015.

Authors:  Dao Nguyen Vinh; Dang Thi Minh Ha; Nguyen Thi Hanh; Guy Thwaites; Maciej F Boni; Hannah E Clapham; Nguyen Thuy Thuong Thuong
Journal:  BMC Infect Dis       Date:  2018-10-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.